Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The retinal implant at the back of the eye. Source: OU
The retinal implant at the back of the eye. Source: OU

Professor Robert MacLaren, Nuffield Laboratory of Ophthalmology, has performed the first retinal implant in the UK, performing the eight hour surgery at the Oxford University Hospitals NHS Trust. The patient, Chris James, had been left completely blind from retinitis pigmentosa, a disease in which retinal cells deteriorate over time. The retinal implants contain 1500 electronic light detectors which act as substitutes for the lost retinal cells. The implant’s electrodes are connected to overlying nerves which relay signals to the optic nerve, with the patient experiencing a pixelated image. A power supply for the device is inserted behind the ear.

Once the implant was switched on, the patient was able to immediately detect light. After some time adjusting to the device, he is now able to recognise basic shape outlines. The device is still in the trial phase, with up to 12 UK patients being included. The manufacturers, Retina Implant of Germany, hope for commercial approval following the trial.

Prof MacLaren said ‘we are all delighted with these initial results. The vision is different to normal ... and it requires a different type of brain processing. We hope, however, that the electronic chips will provide independence for many people who are blind from retinitis pigmentosa.’

Similar stories

European Platform for Neurodegenerative Diseases launches repository of cohorts for researchers

The new Cohort Catalogue will facilitate discovery of over 60 neurodegeneration research cohorts from 17 countries across Europe

Two NDCN students join BNA Scholars Programme

The British Neuroscience Association Scholars Programme was launched in 2021 with a view to improving equality, diversity and inclusion in neuroscience.

Researchers win UK Dementia Research Institute Grand Challenge Award to identify early signs of Alzheimer's

The MRC Brain Network Dynamics Unit has received funding for a multi-year research partnership designed to advance the understanding of early changes to the operations of brain circuits in Alzheimer's disease.

Ophthalmology Conference in Kyiv

On 21 February, Robert MacLaren organised a one-day ophthalmology conference in Kyiv together with Dr Andrii Ruban, President of the Ukrainian Vitreoretinal Society.

Bioelectronic implant offers an intelligent therapy to treat incontinence

The first participants in a clinical trial of a bioelectrical therapy to treat incontinence have received their 'smart' bioelectronic implants.

Direct evidence of reduced NMDA receptors in people with form of encephalitis

NMDAR-antibody encephalitis is an autoimmune brain condition caused by patient’s own antibodies that bind to NMDA (N-Methyl-D-Aspartate) receptors in the synapses between nerve cells.